Dr. Reddy’s Announces the Launch of Amlodipine Besylate and Benazepril Hydrochloride Capsules

Dr. Reddy’s announced it has launched Amlodipine Besylate and Benazepril Hydrochloride capsules, 5 mg/40 mg and 10 mg/40 mg, a bioequivalent generic version of Lotrel capsules, in the U.S. market following the approval by the FDA of Dr. Reddy’s ANDA for amlodipine besylate and benazepril hydrochloride capsules.
MarketWatch